Back to User profile » Dr Suayib Yalcin

Papers published by Dr Suayib Yalcin:


Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer

Kahraman S, Yalcin S

OncoTargets and Therapy 2021, 14:4149-4162

Published Date: 13 July 2021

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO

Journal of Hepatocellular Carcinoma 2020, 7:143-153

Published Date: 16 September 2020

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E

OncoTargets and Therapy 2018, 11:1223-1228

Published Date: 5 March 2018

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors

Yıldız Y, Sokmensuer C, Yalcin S

OncoTargets and Therapy 2016, 9:5809-5817

Published Date: 22 September 2016

A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer

Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S

OncoTargets and Therapy 2016, 9:4815-4820

Published Date: 3 August 2016

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

Benekli M, Yalcin S, Ozkan M, Elkiran ET, Sevinc A, Cabuk D, Coskun HS, Oksuzoglu B, Bayar B, Akbulat A, Ozet A

OncoTargets and Therapy 2015, 8:1-5

Published Date: 15 December 2014

Neuropathic cancer pain: What we are dealing with? How to manage it?

Esin E, Yalcin S

OncoTargets and Therapy 2014, 7:599-618

Published Date: 17 April 2014

A review of the use of somatostatin analogs in oncology

Keskin O, Yalcin S

OncoTargets and Therapy 2013, 6:471-483

Published Date: 26 April 2013